CST Outcomes

October 22, 2007

1 Min Read
The Aesthetic Guide logo in a gray background | The Aesthetic Guide

CST follows-up on recent stories

In our January/February 2007 issue, we covered the latest news on promising new evidence that could address the well-known limitation of fat transplantation used as a filler in plastic and reconstructive surgery. (See “Stemming Time’s Tides.”)
Early evidence suggested that neovascularization can be engendered in a fat transplant by supplementing the implanted tissue with autologous adipose-derived stem cells (ADCs). As reported on consumer cosmetic surgery site www.makemeheal.com, a new device on the market, the Celution System, used to extract ADCs, is now being used in a new and innovative procedure called “Celution,” which has just been approved in the European Union. The technique will first focus on breast reconstruction for women who have undergone a partial mastectomy or lumpectomy. However, breast augmentation through the Celution technique may be a possibility in the future for women looking for minimally invasive, virtually scarless breast augmentation.
The system sterilely disaggregates adipose tissue using a temperature and enzyme-driven process. Within an hour, the surgeon has a syringe containing concentrated stem cells that are injected into the patient’s breast tissue. Within six months post procedure, breasts may enlarge by up to two cup sizes.

Subscribe to receive the latest in aesthetic medicine.
Get breaking developments, expert product comparisons, clinical roundtables, and practice strategies—all for free.